employee from 01.01.2023 until now
Ekaterinburg, Ekaterinburg, Russian Federation
Endometriosis is a chronic hormone–dependent disease caused by the proliferation of tissue similar in structure to the endometrium outside the uterine cavity. The purpose of this review is to highlight the issue of modern methods of endometriosis therapy. The search for literature sources for analysis was carried out on the resources of PubMed, CyberLeninka, Elibrary. Articles for the period from 2020 to 2024 were selected. Main manifestations of endometriosis are dysmenorrhea, dyspareunia, dyschesia, and decreased fertility. According to the World Association of Endometriosis, symptoms of the disease are detected in 38% of women of reproductive age, and in 25-100% the disease occurs in adolescents. Hormone therapy is used to treat endometriosis, including combined oral contraceptive (COC) pill, progestogens, gonadotropin-releasing hormone agonists, aromatase inhibitors, danazol, and nonsteroidal anti-inflammatory drug for symptomatic treatment. Progestogens are recommended as †rst-line drugs. COCs are used as the main method of contraception in women with endometriosis, but they are also e—ective as hormone therapy for endometrioid ovarian cysts. Gonadotropin releasing hormone agonists are prescribed to patients with persistent symptoms after the use of COCs, however, due to their pharmacodynamic e—ects, they are not recommended for adolescents and postmenopausal women. Danazol is currently not used often, as it has many androgen-mediated side e—ects. In addition to drug therapy, surgical interventions are used to determine the localization and excision of foci of endometrioid tissue. Treatment of endometriosis is currently an issue that requires further study due to the prevalence of the disease and the need for an individual approach to the management of patients in di—erent groups.
endometriosis, hormonal therapy, surgical treatment
1. Shmidt A. A., Gayvoronskih D. I., Kremlev D. I., Abashin V. G. Endometrioidnaya bolezn' – sovremennyy vzglyad na problemu. Klinicheskaya medicina. 2021;99(11-12):615-619.
2. Kalaitzopoulos D. R., Samartzis N., Kolovos G. N., Mareti E., Samartzis E. P, Eberhard M., et al. Treatment of endometriosis: a review with comparison of 8 guidelines. BMC Women’s Health. 2021;397(21):3-7.
3. Arafah M., Rashid S., Akhtar M. Endometriosis: A Comprehensive Review. Adv Anat Pathol. 2021:28(1):30-43. doihttps://doi.org/10.1097/pap.0000000000000288.
4. Bekker K. M., Bokor A., Haykinhaymo O., Horn E., Yanssen F., Kizel' L. i dr. Rukovodstvo evropeyskogo obschestva po reprodukcii cheloveka i embriologii (ESHRE): endometrioz (perevod na russkiy pod red.
5. Klinicheskie rekomendacii – Endometrioz – 2024-2025-2026.(25.09.2024). Utverzhdeny Minzdravom RF. URL: http://disuria.ru/_ ld/14/1476_kr24N80MZ.pdf. (Data obrascheniya: 28.01.2025).
6. Orazov M. R., Radzinskiy V. E., Dolgov E. D. Kombinirovannoe lechenie (hirurgiya + gormonoterapiya) pacientok s razlichnymi formami endometrioza. Klinicheskiy razbor v obschey medicine. 2024;5(3):39-46.
7. Kalinkina O. B., Tezikov Yu. V., Lipatov I. S., Krasnova N. A., Mayorova M. O., Brenerova O. N. i dr. Osobennosti diagnostiki i terapii endometrioza. Zdorov'e i obrazovanie v XXI veke. 2022;7(24):5-19.
8. Vishnepol'skaya M. V. Otdalennye rezul'taty sovremennyh shem lecheniya endometrioza. FORCIPE. 2021;4(S1):115.
9. Tihomirov A. L. Endometrioz: kachestvo zhizni, prognoz i profilaktika. Akusherstvo i ginekologiya: Novosti. Mneniya. Obucheniya. 2020; 29(3):132-134. doihttps://doi.org/10.24411/2303-9698-202013022.
10. Chernuha G. E., Dumanovskaya M. R., Il'ina L. M. Ovarial'nyy endometrioz i problema sohraneniya fertil'nosti. Ginekologiya. 2021; 23(2):110-116. doihttps://doi.org/10.26442/20795696.2021.2.200 822.
11. Mitchell J. B., Chetty S., Kathrada F. Progestins in the symptomatic management of endometriosis: a meta-analysis on their effectiveness and safety. BMC Women’s Health. 2022;22(1):4-14. doihttps://doi.org/10.1186/s12905-022-02122-0.
12. Abdikadyrova A. A., Saduakasova Sh. M., Bodykov G. Zh. Sovremennyy vzglyad na problemu endometrioza yaichnikov. Vestnik KazNMU. 2020; (2):11-13.
13. Sibirskaya E. V., Pivazyan L. G., Koltunov I. E., Vyhristyuk Yu. V. Sovremennaya klassifikaciya i metody korrekcii anomal'nyh matochnyh krovotecheniy u zhenschin pozdnego reproduktivnogo vozrasta. Trudnyy
14. Chantalat E., Valera M. C., Vaysse C., Noirrit E., Rusidze M., Weyl A. et al. Estrogen Receptors and Endometriosis. International journal of molecular sciences. 2020; 21(8):2-10. doi:10.3390/ ijms21082815.
15. Marla S., Mortlock S., Heinosalo T., et al. Gene expression profiles separate endometriosis lesion subtypes and indicate a sensitivity of endometrioma to estrogen suppressive treatments through elevated ESR2 expression.
16. Zhan L., Cao Y. Personalized therapy in endometriosis — based on ERα or ERβ expression. BMC Medicine. 2024;217(22):1-2. doi:10.1186/ s12916-024-03415-x.
17. Kudryavceva E. V., Geec A. V., Mangileva Ya. A., Chizhova A. V., Pacyuk O. V. Sovremennye neinvazivnye metody diagnostiki endometrioza. Ural'skiy medicinskiy zhurnal. 2023;22(4):140
18. Holdsworth-Carson S. J., Chung J., Machalek D. A., et al. Predicting disease recurrence in patients with endometriosis: an observational study. BMC Medicine. 2024;320(22):2-32. doihttps://doi.org/10.1186/s12916024-03508-7.
19. Surrey E. S. GnRH agonists in the treatment of symptomatic endometriosis: a review. F&S reports. 2022;4(2):40-45. doi:https://doi.org/10.1016/j.xfre.2022.11.009.
20. Podzolkova N. M., Fadeev I. E., Mass E. E., Poletova T. N., Sumyatina L. V., Denisova T. V. Neinvazivnaya diagnostika i konservativnaya terapiya endometrioza. Ginekologiya. 2022;24(3):167-173.
21. Alekseeva M. N., Haschenko E. P., Uvarova E. V. Osnovnye zven'ya patogeneza endometrioza: giperestrogeniya, immunotolerantnost', prolii disseminaciya endometrioidnyh kletok. Reproduktivnoe zdorov'e
22. Chay V. B., Bakunina A. A., Mikailly G. T. Medikamentoznoe lechenie adenomioza. Obzor literatury. Ginekologiya. 2023;25(2):134-135. do ihttps://doi.org/10.26442/20795696.2023.2.202101.
23. Ahmedova S. R., Omarov N. S. Pokazateli citokinovogo balansa i sosudisto-epitelial'nogo faktora rosta v zavisimosti ot urovnya vitamina D u pacientok s naruzhnym genital'nym endometriozom.
24. Dobrohotova Yu. E., Sofronov A.V. Primenenie vitamina D v lechenii endometrioza. RMZh. Mat' i ditya. 2023;6(2):126-129. doihttps://doi.org/10.32364/2618-8430-2023-6-2-126-129.
25. Denisova A. S., Yarmolinskaya M. I., Tkachenko N. N. Status 25(ON)D u bol'nyh naruzhnym genital'nym endometriozom i klinicheskaya effektivnost' primeneniya kolekal'ciferola v terapii zabolevaniya.
26. Turaeva G. Yu. Effektivnost' primeneniya sovremennyh metodov pri rannem vyyavlenii i lechenii naruzhnogo genital'nogo endometrioza. Ekonomika i socium. 2024;118(3):816-821.
27. Cypurdeeva A. A., Yarmolinskaya M. I., Protasova A. E., Molotkov A. S. Endometrioidnye kisty: sovremennaya strategiya hirurgicheskogo lecheniya. Vestnik Nacional'nogo mediko-hirurgicheskogo Centra im. N. I.
28. Dubinskaya E. D., Gasparov A. S., Dutov A. A., Orazov M. R., Soyunov M. A. Prognozirovanie izmeneniy ovarial'nogo rezerva posle cistektomii pri endometriomah s pomosch'yu ball'noy diagnosticheskoy shkaly.
29. Schippert C., Witte Y., Bartels J., Garcia-Rocha G-S., Jentschke M., Hillemanns P. Reproductive capacity and recurrence of disease after surgery for moderate and severe endometriosis – a retrospective single center
30. Muraoka A., Osuka S., Yabuki A., Bayusula, Yoshihara M., Tanaka H. Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial. Reprod
31. Nirgianakis K., Ma L., McKinnon B., Mueller, M. D. Recurrence Patterns after Surgery in Patients with Different Endometriosis Subtypes: A Long-Term Hospital-Based Cohort Study. Journal of clinical medicine. 2020; 9(2):496.
32. Gusev D. V., Priluckaya V. Yu., Chernuha G. E. Recidivy endometrioidnyh kist yaichnikov i vozmozhnye puti ih snizheniya. Ginekologiya. 2020;22(3):34-38. doihttps://doi.org/10.26442/20795696.2020.3.200144.
33. Somigliana E., Li Piani L., Paffoni A., Salmeri N., Orsi M., Benaglia L. et al. Endometriosis and IVF treatment outcomes: unpacking the process. Reprod Biol Endocrinol. 2023;21(1):107. doihttps://doi.org/10.1186/s12958-023-01157-8.
34. Morcel K., Merviel P., Bouée S. Le-Guillou M., Carlier M., James P., et al. What is the impact of endometriosis and the AFS stage on cumulative pregnancy rates in IVF programs? Reprod Health 2024;21(1):13.
35. Shao W., Li Y., Wang Y. Impact of dienogest pretreatment on IVF-ET outcomes in patients with endometriosis: a systematic review and meta-analysis. J Ovarian Res. 2023;16(1):166. doihttps://doi.org/10.1186/s13048023-01245-8.
36. Habib N., Buzzaccarini G., Centini G., Moawad G.N., Ceccaldi P.F., Gitas G. et al. Impact of lifestyle and diet on endometriosis: a fresh look to a busy corner. Prz Menopauzalny. 2022;21(2):124132.
37. Abramiuk M., Mertowska P., Frankowska K., Świechowska-Starek P., Satora M., Polak G. et al. How Can Selected Dietary Ingredients Influence the Development and Progression of Endometriosis? Nutrients. 2024;16(1):154.
38. Tennfjord M.K., Gabrielsen R., Tellum T. Effect of physical activity and exercise on endometriosis-associated symptoms: a systematic review. BMC Womens Health. 2021;21(1):355. doihttps://doi.org/10.1186/s12905-021-01500-4.
39. Mazur-Bialy A., Tim S., Pepek A., Skotniczna K., Naprawa G. Holistic Approaches in Endometriosis - as an Effective Method of Supporting Traditional Treatment: A Systematic Search and Narrative Review. Reproductive
40. Ravins I. Joseph G., Tene L. The Effect of Practicing «Endometriosis Yoga» on Stress and Quality of Life for Women with Endometriosis: AB Design Pilot Study. Alternative therapies in health and medicine. 2023;29(3):8-14.
